Sign in

You're signed outSign in or to get full access.

Chung-Yi Tsai

Director at Ainos
Board

About Chung-Yi Tsai

Chung-Yi Tsai (age 49) has served on Ainos, Inc. (AIMD) board since April 2021. He is a technology hardware product/business development executive, currently Senior Product Marketing Director at Alpha & Omega Semiconductor (since May 2023). He holds an MBA from Golden Gate University.

Past Roles

OrganizationRoleTenureCommittees/Impact
Alpha & Omega SemiconductorSenior Product Marketing DirectorMay 2023–presentProduct strategy and marketing leadership
Renesas ElectronicsSenior Product Marketing ManagerJun 2020–May 2023Product marketing, portfolio management
Maxim IntegratedExecutive Business ManagerNov 2019–Jun 2022Business development and execution
Intersil CorporationSenior Product Marketing ManagerOct 2013–Nov 2019Product marketing

External Roles

OrganizationRoleTenureNotes
Taiwan Carbon Nano Technology Corporation (TCNT)DirectorJul 2012–presentTCNT controls Ainos KY, Ainos’ controlling shareholder; extensive related-party activity with AIMD

Board Governance

  • Board size and slate: Seven directors; Tsai is a nominee and continuing director (Director since April 2021).
  • Committee assignments: Audit Committee members are Wen‑Han Chang, Yao‑Chung Chiang, and Pao‑Sheng Wei (Chair). Compensation Committee members are Wen‑Han Chang (Chair) and Pao‑Sheng Wei. Tsai is not listed as a member of either committee.
  • Independence: The board determined only Wen‑Han Chang, Yao‑Chung Chiang, and Pao‑Sheng Wei are independent under SEC/Nasdaq rules; Tsai is not named as independent (non‑independent).
  • Governance policies: Hedging prohibited; short sales prohibited; no director/exec stock ownership policy in place; standard indemnification agreements and D&O insurance maintained.
  • Attendance: Number of board/committee meetings and individual attendance rates for 2024/2025 are not disclosed in the proxies.

Fixed Compensation

Metric20232024
Board cash retainer ($)12,000 12,000
Committee cash retainers ($)0 (not a committee member) 0 (not a committee member)
Total cash ($)12,000 12,000

Non‑Employee Director Compensation Policy: Annual Board retainer $12,000; Audit Chair $7,000; Compensation Chair $4,500; Audit member $4,000; Compensation member $3,000. Appointment grant of 22,000 RSUs (adjusted to 4,400 shares post 1:5 reverse split on Dec 14, 2023) vests over three equal installments every six months across three years.

Performance Compensation

Metric20232024
Director stock awards grant-date fair value ($)162,250 0
RSU appointment grant (shares)22,000 pre‑split; 4,400 post‑split vesting over 3 years Ongoing vesting per policy
Special stock awards (Form 4)150,000 shares granted and vested on Mar 10, 2025 (reported Mar 12, 2025)

The board sought shareholder approval to reserve additional “Special Stock Awards”: 2,000,000 shares in Aug 2024; 950,000 shares in Oct 2025; these are supplemental to the 2023 SIP.

Other Directorships & Interlocks

  • TCNT/Ainos KY control structure: TCNT holds majority of Ainos KY; Ainos KY and TCNT together had significant voting power via multiple voting agreements in 2024–2025. Tsai is part of the “Tsai Group” party to a Jan 26, 2024 voting agreement.
  • Related-party transactions:
    • Aug 6, 2024: Exclusive, irrevocable patent license from TCNT to AIMD in exchange for 5,500,000 AIMD shares, giving TCNT direct equity and reinforcing control via Ainos KY—material governance red flag.
    • TCNT product development agreements and patent use fees; prepayments and monthly license fees in 2024.
    • Working capital note from Ainos KY; repaid Oct 7, 2024.

Expertise & Qualifications

  • Functional expertise: Product marketing, semiconductors, hardware business development; MBA credential.
  • Not designated as an Audit Committee Financial Expert; not on audit/comp committees.

Equity Ownership

Metric202320242025
Shares beneficially owned (units)7,333 52,932 54,400
Ownership % of common0.04% <1% (“*”) <1% (“*”)
RSUs vesting within 60 days included?Yes (per footnote across directors) Yes N/A in 2025 table footnotes
Pledged as collateralCompany “not aware of any arrangements, including any pledge…” (general statement)

Insider Trades

Date filedTransaction dateDescriptionSource
Jan 31, 2025Jan 2025Form 4 filed by Tsai; details available via SEC index link
Mar 12, 2025Mar 10, 2025150,000 shares granted and vested as Special Stock Awards to Tsai

Governance Assessment

  • Board role and independence: Tsai is a long‑tenured director (since 2021) but not independent; independence on AIMD’s board is concentrated in three directors (Chang, Chiang, Wei). This limits fully independent oversight, especially given related‑party transactions.
  • Committee participation: Tsai does not serve on the Audit or Compensation Committees, reducing direct involvement in oversight of financial reporting and executive pay.
  • Compensation alignment: Director pay shifted from significant equity awards in 2023 ($162,250) to cash‑only in 2024 ($12,000). The change reduces equity‑based alignment year‑over‑year; reasons are not disclosed.
  • Ownership alignment: Tsai’s beneficial ownership increased from 7,333 (2023) to 52,932 (2024) and 54,400 (2025), still <1%—low “skin‑in‑the‑game” relative to overall control exerted by TCNT/Ainos KY.
  • Conflicts and related parties — RED FLAGS:
    • TCNT license for key patents in exchange for 5.5M shares (Aug 2024), plus ongoing development/licensing arrangements, with Tsai concurrently serving as TCNT director—creates direct interlock and material related‑party exposure.
    • Voting agreements involving the “Tsai Group” concentrate voting power with insiders/affiliates (Ainos KY/TCNT), potentially diluting broader shareholder influence.
  • Investor‑unfriendly policies: No stock ownership guidelines for directors/executives; hedging/short‑sale prohibitions exist, but absence of ownership policy weakens alignment signals.
  • Disclosure gaps: No director attendance rates disclosed; no explicit committee meeting counts for the latest periods; limited transparency on performance criteria for director equity awards.

Overall, Tsai’s dual role with TCNT amid significant related‑party transactions and non‑independent status represents governance risk. Equity ownership remains modest despite influence via voting agreements, and lack of committee roles limits formal oversight engagement. Independent committee chairs and members provide some counterbalance, but concentrated control by TCNT/Ainos KY and special stock award programs merit close monitoring.

Appendix: Board/Committee and Policy References

  • Board nominees and ages; Tsai age 49; Director since April 2021.
  • Audit Committee composition and chair; Compensation Committee composition and chair.
  • Director independence determinations.
  • Non‑Employee Director Compensation Policy details and RSU vesting schedule.
  • Hedging policy and absence of stock ownership policy; indemnification and insurance.